ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2020
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
ResMed (RMD) Tops Q3 EPS by 25c, Revenues Beat
April 30, 2020 4:44 PM EDTResMed (NYSE: RMD) reported Q3 EPS of $1.29, $0.25 better than the analyst estimate of $1.04. Revenue for the quarter came in at $769.5 million versus the consensus estimate of $722.52 million.
Third Quarter 2020 Highlights
Year-over-year revenue grows 16%, non-GAAP operating profit up 31%Balanced growth across product portfolio, software solutions, and global marketsFocused on combating COVID-19 pandemic through increased ventilator production and ongoing partnership and support of key global stakeholdersAll comparisons are to the prior-year period
Revenue increased 16% to $769.5 million; up 17% on a constant currency basisGAAP... More